Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

Clinical trial NCT07285278 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07285278
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Varicella-zoster Virus

Start date: 2025-11-15
Primary completion: 2026-03-09
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.